Reclassification of gabapentin and pregabalin as Schedule 3 drugs
Joint statement agreed by NHS England, the Health & Care Professions Council, the Institute of Chiropodists and Podiatrists, the College of Podiatry, and the Chartered Society of Physiotherapy: From 00:00am on 1st April 2019, gabapentinRead more